Cg Oncology Inc’s recent filing unveils that its Director POST LEONARD E unloaded Company’s shares for reported $43250.0 on Oct 13 ’25. In the deal valued at $43.25 per share,1,000 shares were sold. As a result of this transaction, POST LEONARD E now holds 0 shares worth roughly $0.0.
Then, Mulay James sold 5,903 shares, generating $259,673 in total proceeds. Upon selling the shares at $43.99, the Director now owns 0 shares.
Before that, JAMES MULAY bought 6,557 shares. Cg Oncology Inc shares valued at $266,935 were divested by the Director at a price of $40.71 per share.
Guggenheim initiated its Cg Oncology Inc [CGON] rating to a Buy in a research note published on October 08, 2025; the price target was $90. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid August with a ‘”an Overweight”‘ rating. JP Morgan started covering the stock on May 02, 2025. It rated CGON as “an Overweight”.
Price Performance Review of CGON
On Monday, Cg Oncology Inc [NASDAQ:CGON] saw its stock jump 1.42% to $44.29. Over the last five days, the stock has gained 1.61%. Cg Oncology Inc shares have risen nearly 24.38% since the year began. Nevertheless, the stocks have risen 54.43% over the past one year. While a 52-week high of $45.56 was reached on 10/10/25, a 52-week low of $14.80 was recorded on 04/09/25.
Levels Of Support And Resistance For CGON Stock
The 24-hour chart illustrates a support level at 43.31, which if violated will result in even more drops to 42.32. On the upside, there is a resistance level at 45.15. A further resistance level may holdings at 46.01.
How much short interest is there in Cg Oncology Inc?
A steep rise in short interest was recorded in Cg Oncology Inc stocks on 2025-10-15, growing by 1.21 million shares to a total of 12.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 11.01 million shares. There was a rise of 9.91%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 16, 2025 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $23 price target.
